POSDINEMAB
UNII 6HG8JYS9D6

Substance Identification & Data

This profile provides standardized clinical and technical data for Posdinemab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6HG8JYS9D6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2517973-04-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
6HG8JYS9D6
CAS Registry Number
2517973-04-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
POSDINEMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11987
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
LM-102
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Posdinemab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

POSDINEMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN PHOSPHORYLATED TAU PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL JNJ-63733657 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL JNJ-63733657 .KAPPA.-CHAIN, DIMER
JNJ-63733657
POSDINEMAB [INN]
POSDINEMAB [USAN]